Literature DB >> 29307389

Accelerating cervical cancer control and prevention.

Nicolas Wentzensen1, Mark Schiffman2.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 29307389     DOI： 10.1016/S2468-2667(17)30242-6

Source DB:  PubMed          Journal:  Lancet Public Health


× No keyword cloud information.
  7 in total

1.  Trends and Determinants in Uptake of Cervical Cancer Screening in Spain: An Analysis of National Surveys from 2017 and 2020.

Authors:  Silvia Portero de la Cruz; Jesús Cebrino
Journal:  Cancers (Basel)       Date:  2022-05-18       Impact factor: 6.575

2.  LINC00997/MicroRNA 574-3p/CUL2 Promotes Cervical Cancer Development via Mitogen-Activated Protein Kinase Signaling.

Authors:  Daming Chu; Tengteng Liu; Yuan Yao; Nannan Luan
Journal:  Mol Cell Biol       Date:  2021-07-23       Impact factor: 4.272

3.  Burden of Cervical Cancer in the Eastern Mediterranean Region During the Years 2000 and 2017: Retrospective Data Analysis of the Global Burden of Disease Study.

Authors:  Fereshteh Safaeian; Shidrokh Ghaemimood; Ziad El-Khatib; Sahba Enayati; Roksana Mirkazemi; Bruce Reeder
Journal:  JMIR Public Health Surveill       Date:  2021-05-12

4.  LINC01128 expedites cervical cancer progression by regulating miR-383-5p/SFN axis.

Authors:  Yi Hu; Yan Ma; Jie Liu; Yanlin Cai; Mengmeng Zhang; Xiaoling Fang
Journal:  BMC Cancer       Date:  2019-11-28       Impact factor: 4.430

5.  Long non-coding RNA LINC01535 promotes cervical cancer progression via targeting the miR-214/EZH2 feedback loop.

Authors:  Hongjuan Song; Yuan Liu; Xin Jin; Yang Liu; Yanling Yang; Lei Li; Xuan Wang; Guilin Li
Journal:  J Cell Mol Med       Date:  2019-07-05       Impact factor: 5.310

6.  Redesign of a rapid, low-cost HPV typing assay to support risk-based cervical screening and management.

Authors:  Kanan T Desai; Clement A Adepiti; Mark Schiffman; Didem Egemen; Julia C Gage; Nicolas Wentzensen; Silvia de Sanjose; Robert D Burk; Kayode O Ajenifuja
Journal:  Int J Cancer       Date:  2022-06-24       Impact factor: 7.316

7.  RGMB-AS1/miR-4428/PBX1 axis drives the progression of cervical cancer.

Authors:  Chenge Shen; Beixi Wang; Kaiwen Zhang; Ce Wang; Jiajia Wang; Zhanglu An; Lisha Shu
Journal:  Transl Cancer Res       Date:  2020-05       Impact factor: 1.241
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.